Search details
1.
Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity.
Immunity
; 52(6): 1075-1087.e8, 2020 06 16.
Article
in English
| MEDLINE | ID: mdl-32445619
2.
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.
Blood
; 122(5): 684-93, 2013 Aug 01.
Article
in English
| MEDLINE | ID: mdl-23801635
3.
ADAR1-mediated RNA editing promotes B cell lymphomagenesis.
iScience
; 26(6): 106864, 2023 Jun 16.
Article
in English
| MEDLINE | ID: mdl-37255666
4.
ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts.
Front Cell Dev Biol
; 10: 1080626, 2022.
Article
in English
| MEDLINE | ID: mdl-36684421
5.
MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq.
Mol Ther Nucleic Acids
; 25: 515-523, 2021 Sep 03.
Article
in English
| MEDLINE | ID: mdl-34589274
6.
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.
J Virol
; 83(16): 8108-21, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19515783
7.
Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2.
Int J Oncol
; 33(4): 823-32, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18813797
8.
CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells.
Cancer Immunol Res
; 6(5): 517-527, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29514797
9.
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells.
Oncoimmunology
; 5(7): e1116674, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27622013
10.
Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.
Cancer Res
; 74(13): 3429-40, 2014 Jul 01.
Article
in English
| MEDLINE | ID: mdl-24780758
11.
Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity.
Int J Oncol
; 40(3): 840-50, 2012 Mar.
Article
in English
| MEDLINE | ID: mdl-22102168
12.
Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Cancer Res
; 71(18): 5998-6009, 2011 Sep 15.
Article
in English
| MEDLINE | ID: mdl-21764762
13.
Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence.
Vaccine
; 27(40): 5480-7, 2009 Sep 04.
Article
in English
| MEDLINE | ID: mdl-19616491
14.
A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes.
Int J Cancer
; 118(3): 658-67, 2006 Feb 01.
Article
in English
| MEDLINE | ID: mdl-16108015
15.
Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence.
Int J Cancer
; 119(2): 328-38, 2006 Jul 15.
Article
in English
| MEDLINE | ID: mdl-16470838
16.
T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine.
Vaccine
; 23(19): 2439-53, 2005 Mar 31.
Article
in English
| MEDLINE | ID: mdl-15752830
Results
1 -
16
de 16
1
Next >
>>